Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial.

MLA

Simpson, Kit N., et al. “Drivers of Costs Associated with Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial.” Stroke, vol. 45, no. 6, June 2014, pp. 1791–98. EBSCOhost, https://doi.org/10.1161/STROKEAHA.113.003874.

APA

Simpson, K. N., Simpson, A. N., Mauldin, P. D., Hill, M. D., Yeatts, S. D., Spilker, J. A., Foster, L. D., Khatri, P., Martin, R., Jauch, E. C., Kleindorfer, D., Palesch, Y. Y., & Broderick, J. P. (2014). Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke, 45(6), 1791–1798. https://doi.org/10.1161/STROKEAHA.113.003874

Chicago

Simpson, Kit N, Annie N Simpson, Patrick D Mauldin, Michael D Hill, Sharon D Yeatts, Judith A Spilker, Lydia D Foster, et al. 2014. “Drivers of Costs Associated with Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial.” Stroke 45 (6): 1791–98. doi:10.1161/STROKEAHA.113.003874.